- This event has passed.
Strategic Storytelling and the Axonics Story
Mr. Cohen is an expert at leveraging medical technology, regulatory strategy, clinical development, and developing commercial products. He is highly skilled at raising equity and debt capital, licensing, strategic partnerships, mergers and acquisitions, investor relations and strategic planning. While under his leadership in October 2018, Axonics raised $120 million in an IPO and has approval for its r-SNM System in the EU, Australia, and Canada.
Tickets are not available as this event has passed.